Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus

ConclusionsSGLT2i was more likely to be newly prescribed to patients with CVD-HF and CKD, older patients, and to be prescribed in earlier treatment lines in recent years. Obesity and HF were predictor of SGLT2i prescriptions in the first line.

http://link.springer.com/10.1007/s13340-022-00577-y

Source: Diabetology International - March 16, 2022 Category: Endocrinology Source Type: research